Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Heidenreich

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Cell Reports|September 23, 2014
Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewalAnetta Ptasinska, Salam A Assi, Natalia Martinez-Soria, et al.
Journal of Medicinal Chemistry|September 12, 2022
A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid LeukemiaJosé Luis Marín-Rubio, Rachel E Peltier-Heap, Maria Emilia Dueñas, et al.
Molecular Cancer Research : MCR|July 10, 2020
Exposure of Patient-Derived Mesenchymal Stromal Cells to TGFB1 Supports Fibrosis Induction in a Pediatric Acute Megakaryoblastic Leukemia ModelTheresa Hack, Stefanie Bertram, Helen Blair, et al.
Iscience|April 19, 2024
Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1Daniel J L Coleman, Peter Keane, Paulynn S Chin, et al.
Pharmaceutics|June 28, 2023
Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid NanoparticlesLaura E Swart, Marcel H A M Fens, Anita van Oort, et al.
Haematologica|February 17, 2018
Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21Paul B Sinclair, Helen H Blair, Sarra L Ryan, et al.
Nature Communications|February 14, 2024
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growthSophie G Kellaway, Sandeep Potluri, Peter Keane, et al.
Leukemia|December 5, 2024
HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemiaSaioa Arza-Apalategi, Branco M H Heuts, Saskia M Bergevoet, et al.
Blood Advances|May 24, 2018
Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductaseSarah E Fordham, Helen J Blair, Claire J Elstob, et al.
Nature Medicine|March 15, 2022
Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemiaEleonora Khabirova, Laura Jardine, Tim H H Coorens, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Cell Reports|September 23, 2014
Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewalAnetta Ptasinska, Salam A Assi, Natalia Martinez-Soria, et al.
Journal of Medicinal Chemistry|September 12, 2022
A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid LeukemiaJosé Luis Marín-Rubio, Rachel E Peltier-Heap, Maria Emilia Dueñas, et al.
Molecular Cancer Research : MCR|July 10, 2020
Exposure of Patient-Derived Mesenchymal Stromal Cells to TGFB1 Supports Fibrosis Induction in a Pediatric Acute Megakaryoblastic Leukemia ModelTheresa Hack, Stefanie Bertram, Helen Blair, et al.
Iscience|April 19, 2024
Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1Daniel J L Coleman, Peter Keane, Paulynn S Chin, et al.
Pharmaceutics|June 28, 2023
Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid NanoparticlesLaura E Swart, Marcel H A M Fens, Anita van Oort, et al.
Haematologica|February 17, 2018
Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21Paul B Sinclair, Helen H Blair, Sarra L Ryan, et al.
Nature Communications|February 14, 2024
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growthSophie G Kellaway, Sandeep Potluri, Peter Keane, et al.
Leukemia|December 5, 2024
HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemiaSaioa Arza-Apalategi, Branco M H Heuts, Saskia M Bergevoet, et al.
Blood Advances|May 24, 2018
Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductaseSarah E Fordham, Helen J Blair, Claire J Elstob, et al.
Nature Medicine|March 15, 2022
Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemiaEleonora Khabirova, Laura Jardine, Tim H H Coorens, et al.
Pageof 10